or
forgot password
  • cancer clinical trials in eugene, OR

  • Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Willamette Valley Clinical Studies Williamette Valley Cancer
    Eugene, Oregon 97404
    Metastatic Renal Cell Carcinoma
    Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Willamette Valley Cancer Center - Eugene
    Eugene, Oregon 97401
    Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    A Study in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Non-Small-Cell Lung Carcinoma
    Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Carcinoma of Urinary Tract, Urethral Carcinoma, Carcinoma of Ureter, Carcinoma of Renal Pelvis
    A Safety Study in Patients With Advanced Solid Tumors
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Advanced Solid Tumors
    NP2 Enkephalin For Treatment of Intractable Cancer Pain
    Pain Research of Oregon
    Eugene, Oregon 97401
    Intractable Pain, Neoplasms
    Nicotine Lozenges and Assisted Self-help for Smokeless Tobacco Cessation
    Oregon Research Insititute
    Eugene, Oregon 97403
    Smokeless Tobacco Cessation
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Non-Small Cell Lung Cancer (NSCLC)
    A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
    Willamette Valley Cancer and Research / USOR
    Eugene, Oregon 97401
    Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Study of Ruxolitinib in Pancreatic Cancer Patients

    Eugene, Oregon
    Metastatic Pancreatic Adenocarcinoma
    Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
    Willamette Valley Cancer and Research / USOR
    Eugene, Oregon 97401
    Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Solid Tumors
    Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
    Sandoz Investigational Site
    Eugene, Oregon 97401
    Chemotherapy-induced Neutropenia, Breast Cancer
    A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

    Eugene, Oregon
    Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer
    A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Chronic Lymphocytic Leukemia
    Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
    Willamette Valley Clinical Studies Williamette Valley Cancer
    Eugene, Oregon 97404
    Dose Escalation, Safety, Preliminary Efficacy, Advanced Solid Tumors, Metastatic Breast Cancer, Advanced Pancreatic Adenocarcinoma, Metastatic Colorectal Cancer, Recurrent Glioblastoma Multiforme
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    Willamette Valley Cancer Center
    Eugene, Oregon 97401-8122
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
    Willamette Valley Cancer and Research / USOR
    Eugene, Oregon 97401
    Hodgkin Disease
    A Moderate to Severe Rheumatoid Arthritis Study
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Rheumatoid Arthritis
    A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Squamous Non Small Cell Lung Cancer
    Relation of Consummatory and Anticipatory Food Reward to Obesity
    Oregon Research Institute
    Eugene, Oregon 97403
    Weight Gain, Food Habits
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Advanced Clinical Trials
    Eugene, Oregon 97401
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    Oregon Urology Specialists
    Eugene, Oregon 97401
    Prostate Cancer
    Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
    Oregon Urology Specialists
    Eugene, Oregon 97401
    Prostatic Neoplasms
    Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia
    PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Melanoma, Breast Neoplasms, Carcinoma, Renal Cell, Lymphoma, T-Cell, Carcinoma, Non-Small-Cell Lung